Vertex Pharmaceuticals Incorporated (ETR:VX1)
Germany flag Germany · Delayed Price · Currency is EUR
388.25
+1.85 (0.48%)
May 16, 2025, 5:35 PM CET

Revenue by Product

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 2012 - 2020
Kalydeco
-
Log In
Log In
Log In
Log In
Upgrade
Kalydeco Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other Product
-
Log In
Log In
Log In
Log In
Upgrade
Other Product Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other CF Product
745.30M
Log In
Log In
Log In
Log In
Upgrade
Other CF Product Growth
-12.67%
Log In
Log In
Log In
Log In
Upgrade
Orkambi
-
Log In
Log In
Log In
Log In
Upgrade
Orkambi Growth
-
Log In
Log In
Log In
Log In
Upgrade
Symdeko / Symkevi
-
Log In
Log In
Log In
Log In
Upgrade
Symdeko / Symkevi Growth
-
Log In
Log In
Log In
Log In
Upgrade
Trikafta / Kaftrio
10.29B
Log In
Log In
Log In
Log In
Upgrade
Trikafta / Kaftrio Growth
10.28%
Log In
Log In
Log In
Log In
Upgrade